Levy, Ofer
- Boston Children's Hospital · Pediatrics (investigator's affiliation)
- Boston Children's Hospital · Microbiology & Immunology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,905
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,905
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Levy, Ofer as a PI. Multi-PI records show the full award amount for context.
- 5U19AI168643-02U19Contact PIImmune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthmaBoston Children's Hospital · Pediatrics (investigator's affiliation)$1.5Maward amount
- 75N93019C00044-P00014-9999-1N01Contact PISmall-molecule adjuvants testing pipeline (Influenza)Boston Children's Hospital · Microbiology & Immunology (topic-inferred)$1.4Maward amount
Award organization
Organizations that administered FY2023 awards listing Levy, Ofer as a PI.
FY2023 award administered by Boston Children's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardBoston Children's Hospital
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2010$2M Cumulative Funding
- 2014$5M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #2037
- 2014Entered Top 25% NationallyRanked #2037
- 2015Entered Top 10% NationallyRanked #1876
- 2016$10M Cumulative Funding
- 2017Entered Top 5% NationallyRanked #589
- 2019$25M Cumulative Funding
- 2019Entered Top 1% NationallyRanked #190
- 2022$50M Cumulative Funding